| Name | STING agonist-20 |
|---|---|
| Synonyms | 3H-Imidazo[4,5-b]pyridine-6-cboxamide, 3-[(2E)-4-[5-(aminocbonyl)-2-[[(4-ethyl-2-methyl-5-oxazolyl)carbonyl]amino]-7-(3-hydroxypropoxy)-1H-benzimidazol-1-yl]-2-buten-1-yl]-2-[[(4-ethyl-2-methyl-5-oxazolyl)carbonyl]amino] |
| Description | STING agonist-20 (compound 95) is a potent STING agonist used in the synthesis of XMT-2056. STING agonist-20 can be used as a vaccine adjuvant in the study of cancer and other inflammatory, immune diseases[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Jeremy R. DUVALL, et al. Sting agonist compounds and methods of use. US20210032269. |
| Molecular Formula | C36H39N11O8 |
|---|---|
| Molecular Weight | 753.76 |